Jim Simons’s Vigil Neuroscience VIGL Stock Holding History

Jim Simons’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-535,800	Closed	-$4.26M	–	3970
2025 Q2	$4.26M	Buy	535,800 +316,400	+144%	+$1.42M	0.01%	1628
2025 Q1	$391K	Sell	219,400 -147,900	-40%	-$332K	﹤0.01%	2832
2024 Q4	$624K	Buy	367,300 +321,300	+698%	+$949K	﹤0.01%	2748
2024 Q3	$156K	Sell	46,000 -25,500	-36%	-$94.5K	﹤0.01%	3173
2024 Q2	$286K	Buy	71,500 +11,536	+19%	+$39.5K	﹤0.01%	2927
2024 Q1	$204K	Buy	+59,964	New	+$187K	﹤0.01%	3223
2022 Q3	–	Sell	-37,488	Closed	-$97K	–	4437
2022 Q2	$97K	Buy	37,488 +17,447	+87%	+$68.9K	﹤0.01%	3860
2022 Q1	$141K	Buy	+20,041	New	+$264K	﹤0.01%	3730

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Jim Simons's VIGL Position: Q3 2025 in Review

Jim Simons sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 535,800 shares — an estimated $4.26M sold.

Jim Simons first reported a position in VIGL in Q1 2022 and held it in 8 quarters. The position peaked at $4.26M in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Jim Simons reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Jim Simons sold 535,800 Vigil Neuroscience shares in Q3 2025, an estimated $4.26M.
Jim Simons first reported a position in Vigil Neuroscience in Q1 2022 and held it in 8 quarters.
Jim Simons's Vigil Neuroscience position peaked at $4.26M in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.